Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Iterum Therapeutics plc - Ordinary Share (NQ:ITRM)

0.6920 -0.0080 (-1.14%)
Streaming Delayed Price Updated: 9:36 AM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Iterum Therapeutics plc - Ordinary Share

< Previous 1 2 3 4 5 6 7 8 9 Next >
ITRM Reports Results
Via The Motley Fool
Topics Intellectual Property
Iterum Therapeutics PLC (NASDAQ:ITRM) Reports Wider Q2 2025 Loss, Market Optimistic Ahead of ORLYNVAH Launch
Iterum Therapeutics PLC reports Q2 2025 earnings with a wider loss than expected, but stock rises 4.15% pre-market as investors anticipate ORLYNVAH's August 2025 launch. Cash reserves extend into... 
Via Chartmill
Earnings Scheduled For August 5, 2025
 
Via Benzinga
Insights Ahead: Iterum Therapeutics's Quarterly Earnings
 
Via Benzinga
Which stocks are moving after the closing bell on Monday?
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
A Look Ahead: Iterum Therapeutics's Earnings Forecast
 
Via Benzinga
A Look at Iterum Therapeutics's Upcoming Earnings Report
 
Via Benzinga
Iterum Therapeutics's Earnings: A Preview
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Top movers in Tuesday's pre-market session
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Earnings Scheduled For February 7, 2025
 
Via Benzinga
Earnings Scheduled For May 13, 2025
 
Via Benzinga
Wall Street Drops On Tariffs Threat, Dollar Rises, Uber Rockets On Ackman's Tweet: What's Driving Markets Friday?
Wall Street slumped into negative territory late in the week as renewed fears over inflation and trade tariffs eroded risk appetite. 
Via Benzinga
Topics Economy World Trade
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Earnings Scheduled For November 14, 2024
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships
Iterum Therapeutics' Orlynvah receives FDA approval for treating uncomplicated UTIs in adult women, marking its first approved indication and a U.S. first for oral penems. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q2 2024
ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q1 2024
ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q4 2023
ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Earnings Scheduled For March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Why Iterum Therapeutics Stock Is Trending Today
Iterum Therapeutics announced positive topline results from its REASSURE (REnewed ASsessment of Sulopenem in uUTI caused by Resistant Enterobacterales) Phase 3 clinical trial comparing oral sulopenem... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Insiders Buying Iterum Therapeutics And 3 Other Stocks Under $3
The Dow Jones index closed higher by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.